Literature DB >> 15050116

Genetic and epigenetic modifications associated with human ooplasm donation and mitochondrial heteroplasmy - considerations for interpreting studies of heritability and reproductive outcome.

E Scott Sills1, Takumi Takeuchi, Michael J Tucker, Gianpiero D Palermo.   

Abstract

The mitochondrial heteroplasmy present in offspring from IVF and human ooplasm donation is troublesome and merits further exploration in a debate that is already complex and controversial. Improving the understanding of mitochondrial genomics in this context is important because mitochondriopathies can impact crucial cellular processes in renal, cardiovascular, central nervous, and endocrine systems. Relevant epigenetic consequences of mitochondrial heteroplasmy include associated abnormalities in mitochondrial translation products. Furthermore, as transmission and inheritance patterns of mtDNA are species-specific, it remains to be proven if findings derived from animal studies are applicable to human offspring. As an alternative to gamete research and proteomics based on animal experimentation, continued molecular characterization of the de novo human mitochondriopathies is posed to offer further insights regarding mitochondrial heteroplasmy. In this context, because knowledge of human mitochondrial genetics remains limited and the risks associated with ooplasm donation cannot be quantified, we do not favor its use for our patients at present. However, the small number of infants already conceived from this experimental approach warrant careful longitudinal evaluation. In particular, observational study of the few children born after ooplasm donation could provide opportunities to assess human mtDNA transmission and inheritance. Such findings could help identify features distinguishing natural mtDNA heteroplasmy from heteroplasmy observed after ooplasm donation. Future investigations should also quantify the degree any such heteroplasmy can exist innocuously. Disclosure of mtDNA mutations potentially affecting children conceived from IVF and ooplasm donation must be included during patient education at centers contemplating such treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050116     DOI: 10.1016/j.mehy.2003.10.008

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

Review 1.  Inherited mitochondrial genomic instability and chemical exposures.

Authors:  Sherine S L Chan
Journal:  Toxicology       Date:  2017-07-26       Impact factor: 4.221

Review 2.  Transmission of mitochondrial DNA diseases and ways to prevent them.

Authors:  Joanna Poulton; Marcos R Chiaratti; Flávio V Meirelles; Stephen Kennedy; Dagan Wells; Ian J Holt
Journal:  PLoS Genet       Date:  2010-08-12       Impact factor: 5.917

3.  Mitochondria transfer can enhance the murine embryo development.

Authors:  Yu-Chiao Yi; Ming-Jer Chen; Jason Yen-Ping Ho; Hwa-Fen Guu; Esther Shih-Chu Ho
Journal:  J Assist Reprod Genet       Date:  2007-08-29       Impact factor: 3.412

4.  Intraovarian platelet-rich plasma administration could improve blastocyst euploidy rates in women undergoing in vitro fertilization.

Authors:  Zaher Merhi; Serin Seckin; Marco Mouanness
Journal:  Clin Exp Reprod Med       Date:  2022-08-31

5.  Normalized Ploidy Following 20 Consecutive Blastocysts with Chromosomal Error: Healthy 46, XY Pregnancy with IVF after Intraovarian Injection of Autologous Enriched Platelet-derived Growth Factors.

Authors:  E Scott Sills; Natalie S Rickers; Channel S Svid; J M Rickers; Samuel H Wood
Journal:  Int J Mol Cell Med       Date:  2019-05-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.